SCHEMBL17457016

SCHEMBL17457016

C=CCOC(=O)c1ccc2cc[nH]c2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.54
▸ HSD17B10 Q99714 3/20 0.54
▸ KDM4E B2RXH2 3/20 0.54
▸ HPGD P15428 1/20 0.54
▸ ENPP2 Q13822 1/20 0.54
▸ SNCA P37840 1/20 0.45
▸ MAPT P10636 2/20 0.44
▸ TAS1R3 Q7RTX0 1/20 0.44
▸ TAS1R1 Q7RTX1 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ ESR1 P03372 4/20 0.43
▸ HDAC1 Q13547 3/20 0.42
▸ HDAC2 Q92769 3/20 0.42
▸ HDAC3 O15379 2/20 0.42
▸ HDAC4 P56524 2/20 0.42
▸ HDAC7 Q8WUI4 2/20 0.42
▸ HDAC10 Q969S8 2/20 0.42
▸ HDAC11 Q96DB2 2/20 0.42
▸ HDAC8 Q9BY41 2/20 0.42
▸ HDAC6 Q9UBN7 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30107706 0.81 CYP3A4 (0.55) ALDH1A1HSD17B10KDM4EHPGDSNCA
SCHEMBL429872 0.81 CYP3A4 (0.55) ALDH1A1HSD17B10KDM4EHPGDSNCA
SCHEMBL827892 0.81 ALDH1A1 (0.58) ALDH1A1HSD17B10KDM4EHPGDENPP2
SCHEMBL8387112 0.81 NLRP3 (0.45) ALDH1A1HSD17B10KDM4EHPGDENPP2
SCHEMBL17386426 0.80 CYP3A4 (0.53) ALDH1A1HSD17B10KDM4EHPGDSNCA
SCHEMBL29012860 0.79 ALDH1A1 (0.57) ALDH1A1HSD17B10KDM4EHPGDENPP2
SCHEMBL27683925 0.78 ALDH1A1 (0.55) ALDH1A1HSD17B10KDM4EHPGDENPP2
SCHEMBL28756834 0.77 ESR1 (0.55) ALDH1A1HSD17B10KDM4EHPGDENPP2
SCHEMBL7908275 0.76 ALDH1A1 (0.56) ALDH1A1HSD17B10KDM4EHPGDENPP2
SCHEMBL5135053 0.76 SNCA (0.49) ALDH1A1HSD17B10KDM4EHPGDSNCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9315490-B2 2,5-substituted pyrimidines GRUENENTHAL GMBH (DE) 2016-04-19 — — US disclosed
US-20160024053-A1 Novel 2,5-Substituted Pyrimidines GRUENENTHAL GMBH (DE) 2016-01-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160024053-A1 Novel 2,5-Substituted Pyrimidines PDE4B, PDE4A, PDE12 ALDH1A1 337/4885HSD17B10 1237/4885KDM4E 1006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback